These announcements are available on the Neurotech and ASX websites! You'll find it much easier to manage — and keep! — your money if you follow your investments.
Jan 8th: Investigators from the Carrick Institute commenced compiling and analysing the data from the study in preparation for submission of their findings for publication, but have decided that a recreational and "team-building" break in the Bahamas would be beneficial. The final results of the study will not be available to Neurotech or the public until the investigators are suitably refreshed and tanned and they feel like publishing the results. As a fully independent study, Neurotech has had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; decision to submit the manuscript for publication, or choice of venue for team vacations.
Jan 10th: When the Carrick Institute advised that the US Clinical Trial had reached the milestone of having completed data collection, the Company was also notified that the final results of the study would not be made available to Neurotech or the public until the investigation has been published, as stated in the announcement of 8 January 2018. ... Based on our understanding of the nature of these trials, the Company’s expectation now is that the results will become public within a few months of the team's return from the Bahamas, which will be concurrent with publication of these results and submission to the US FDA.
NTI Price at posting:
17.5¢ Sentiment: Hold Disclosure: Held
